PT Kalbe Farma Tbk. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 13,874,586.04 million compared to IDR 12,370,426.66 million a year ago. Net income was IDR 1,636,948.66 million compared to IDR 1,497,284.96 million a year ago. Basic earnings per share from continuing operations was IDR 35.11 compared to IDR 31.94 a year ago.